This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Lanzhou University, Tencent Technology (Shenzhen) Company Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Xiaojun Yao: Innovator in Glucagon Receptor Antagonism
Introduction
Xiaojun Yao is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of pharmacology, particularly in the development of glucagon receptor antagonists. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Xiaojun Yao holds a patent for a glucagon receptor antagonist and its use. The patent describes a compound that includes compound A, or its isomers, metabolites, prodrugs, pharmaceutically acceptable esters, or salts. This glucagon receptor antagonist features a novel skeleton structure and demonstrates a low half maximal inhibitory concentration on the glucagon receptor, indicating its potential effectiveness in therapeutic applications.
Career Highlights
Throughout his career, Xiaojun Yao has worked with notable institutions, including Lanzhou University and Tencent Technology (Shenzhen) Company Limited. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Xiaojun Yao has collaborated with esteemed colleagues such as Qifeng Bai and Tingyang Xu. These partnerships have enriched his research and expanded the impact of his innovations in the scientific community.
Conclusion
Xiaojun Yao's contributions to the field of glucagon receptor antagonism highlight his role as an influential inventor. His patent and collaborations reflect his commitment to advancing medical research and improving therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile